- Medical School - University of Michigan Medical School (2003-2007)
- Fellowship - University of Michigan Health System (2011-2012), Surgical Pathology
- Fellowship - University of Michigan Health System (2012-2013), Gastroenterology & Liver Diseases
- Residency - University of Michigan Health System (2007-2011), Anatomic & Clinical Pathology
Dr. Suntrea Hammer received her Doctor of Medicine degree from the University of Michigan in Ann Arbor, Michigan. She completed additional training in Anatomic and Clinical Pathology, as well as focused fellowship training in general surgical pathology and gastrointestinal and liver pathology at the University of Michigan. Her practice focuses on neoplastic and inflammatory pathology with an emphasis on the liver and the gastrointestinal tract.
Her research interests include neuroendocrine tumors of the gastrointestinal tract, neoplasms of the liver and gastrointestinal and pancreatobiliary tracts, and medical education.
In 2019, Dr. Hammer was named a Texas Monthly Super Doctor Rising Star.
- United States and Canadian Academy of Pathology (2007), Membership Committee
- American Society of Clinical Pathologists (2007), Education Committee
- American Gastroenterological Association (2011)
- Texas Society of Pathologists (2014)
- College of American Pathologists (2007)
A Novel Th17-Prone CD146+CCR5+ T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease
Wei Li, Liangyi Liu, Aurelie Gomez, Qing Zhang, Jilu Zhang, Abdulraouf Ramadan, Christen L Mumaw, Joel K. Greenson, Suntrea Hammer, Jingmei Lin, Thomas M. Braun, Di Jiang, Elizabeth Virts, Stephanie L Kelich, Hong Wei Chu, Samir Hanash, Helmut Hanenberg and Sophie Paczesny Blood 2014 124 21
Pancreatoblastoma: a rare, adult pancreatic tumor with many faces.
Hammer ST, Owens SR Archives of pathology & laboratory medicine 2013 Sep 137 9 1224-6
Novel Application of Extracorporeal Photopheresis as Treatment of Graft-versus-Host Disease Following Liver Transplantation.
Brown TJ, Gentry C, Hammer ST, Hwang CS, Vusirikala M, Patel PA, Matevosyan K, Tujios SR, Mufti AR, Collins RH ACG case reports journal 2017 4 e48
Esterase-activatable ß-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
Ma X, Huang X, Moore Z, Huang G, Kilgore JA, Wang Y, Hammer S, Williams NS, Boothman DA, Gao J Journal of controlled release : official journal of the Controlled Release Society 2015 Feb 200C 201-211
Beyond acute appendicitis: imaging and pathologic spectrum of appendiceal pathology.
Gaetke-Udager K, Maturen KE, Hammer SG Emergency radiology 2014 Oct 21 5 535-42
The clinical significance of duodenal lymphocytosis with normal villus architecture.
Hammer ST, Greenson JK Archives of pathology & laboratory medicine 2013 Sep 137 9 1216-9
Low Paneth cell numbers at onset of gastrointestinal GVHD identify patients at high risk for non-relapse mortality.
Levine JE, Huber E, Hammer ST, Harris AC, Greenson JK, Braun TM, Ferrara JL, Holler E Blood 2013 Jun
Sporadic lymphoplasmacytic cholecystitis: a clinicopathologic entity.
Hammer ST, Appelman HD American journal of clinical pathology 2014 Aug 142 2 209-12
Lymphocytic esophagitis: an update on histologic diagnosis, endoscopic findings, and natural history.
Patil DT, Hammer S, Langer R, Yantiss RK Annals of the New York Academy of Sciences 2018 Dec 1434 1 185-191
Robot-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparison of short-term surgical outcomes and immediate costs.
Advincula AP, Xu X, Goudeau S, Ransom SB Journal of minimally invasive gynecology 2007 Nov-Dec 14 6 698-705
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as retroperitoneal fibrosis.
Hammer ST, Jentzen JM, Lim MS Human pathology 2011 Nov 42 11 1810-2
- A Novel Th17-Prone CD146+CCR5+ T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease